RS65253B1 - Sinteza jedinjenja estra organoborne kiseline i organoborne kiseline - Google Patents

Sinteza jedinjenja estra organoborne kiseline i organoborne kiseline

Info

Publication number
RS65253B1
RS65253B1 RS20240260A RSP20240260A RS65253B1 RS 65253 B1 RS65253 B1 RS 65253B1 RS 20240260 A RS20240260 A RS 20240260A RS P20240260 A RSP20240260 A RS P20240260A RS 65253 B1 RS65253 B1 RS 65253B1
Authority
RS
Serbia
Prior art keywords
synthesis
acid compounds
boronic ester
boronic
ester
Prior art date
Application number
RS20240260A
Other languages
English (en)
Inventor
Fraser I Pickersgill
John Bishop
Young Lo
Fang-Ting Chui
Vithalanand R Kulkarni
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34968044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS65253(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of RS65253B1 publication Critical patent/RS65253B1/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
RS20240260A 2004-03-30 2005-03-24 Sinteza jedinjenja estra organoborne kiseline i organoborne kiseline RS65253B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55753504P 2004-03-30 2004-03-30
EP21197526.3A EP4008721B1 (en) 2004-03-30 2005-03-24 Synthesis of boronic ester and acid compounds

Publications (1)

Publication Number Publication Date
RS65253B1 true RS65253B1 (sr) 2024-03-29

Family

ID=34968044

Family Applications (4)

Application Number Title Priority Date Filing Date
RS20211565A RS62738B1 (sr) 2004-03-30 2005-03-24 Sinteza jedinjenja estra organoborne kiseline i organoborne kiseline
RS20140186A RS53259B (sr) 2004-03-30 2005-03-24 Sinteza bortezomiba
RS20110502A RS51983B (sr) 2004-03-30 2005-03-24 Sinteza jedinjenja estra organoborne kiseline i organoborne kiseline
RS20240260A RS65253B1 (sr) 2004-03-30 2005-03-24 Sinteza jedinjenja estra organoborne kiseline i organoborne kiseline

Family Applications Before (3)

Application Number Title Priority Date Filing Date
RS20211565A RS62738B1 (sr) 2004-03-30 2005-03-24 Sinteza jedinjenja estra organoborne kiseline i organoborne kiseline
RS20140186A RS53259B (sr) 2004-03-30 2005-03-24 Sinteza bortezomiba
RS20110502A RS51983B (sr) 2004-03-30 2005-03-24 Sinteza jedinjenja estra organoborne kiseline i organoborne kiseline

Country Status (41)

Country Link
US (14) US7714159B2 (sr)
EP (5) EP4008721B1 (sr)
JP (4) JP4558039B2 (sr)
KR (1) KR100939598B1 (sr)
CN (5) CN103396427B (sr)
AR (3) AR049374A1 (sr)
AT (1) ATE521612T1 (sr)
AU (1) AU2005230930B2 (sr)
BR (1) BRPI0509587A (sr)
CA (4) CA2859119A1 (sr)
CL (2) CL2010000350A1 (sr)
CR (1) CR8653A (sr)
CY (3) CY1112053T1 (sr)
DK (4) DK1756121T3 (sr)
DO (1) DOP2011000293A (sr)
EA (1) EA012927B1 (sr)
EC (1) ECSP066960A (sr)
ES (3) ES2371652T3 (sr)
FI (1) FI4008721T3 (sr)
HK (4) HK1100004A1 (sr)
HR (3) HRP20212002T1 (sr)
HU (1) HUE056859T2 (sr)
IL (3) IL178250A (sr)
LT (2) LT3385267T (sr)
ME (1) ME01975B (sr)
MX (1) MX367324B (sr)
MY (1) MY145427A (sr)
NL (3) NL1028639C2 (sr)
NO (4) NO338905B1 (sr)
NZ (3) NZ598172A (sr)
PE (3) PE20060162A1 (sr)
PL (3) PL3385267T3 (sr)
PT (4) PT1756121E (sr)
RS (4) RS62738B1 (sr)
SG (5) SG10201600029PA (sr)
SI (3) SI3385267T1 (sr)
TW (1) TWI386212B (sr)
UA (1) UA90108C2 (sr)
UY (3) UY28830A1 (sr)
WO (1) WO2005097809A2 (sr)
ZA (1) ZA200608689B (sr)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
ME01975B (me) 2004-03-30 2015-05-20 Millennium Pharm Inc Sinteza jedinjenja estra organoborne kiseline i organoborne kiseline
WO2008075376A1 (en) * 2006-12-18 2008-06-26 Natco Pharma Limited Polymorphic forms of bortezomib and process for their preparation
WO2009004350A1 (en) * 2007-07-03 2009-01-08 Pliva Hrvatska D.O.O. Methods for preparing bortezomib and intermediates used in its manufacture
EP2178888B1 (en) 2007-08-06 2012-07-04 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
EA034601B1 (ru) * 2007-08-06 2020-02-25 Милленниум Фармасьютикалз, Инк. Способ получения бороновых кислот
US7442830B1 (en) 2007-08-06 2008-10-28 Millenium Pharmaceuticals, Inc. Proteasome inhibitors
AU2016253697A1 (en) * 2007-08-06 2016-11-24 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
US20110118274A1 (en) * 2007-08-23 2011-05-19 Cornell Research Foundation, Inc. Proteasome inhibitors and their use in treating pathogen infection and cancer
BRPI0816807A2 (pt) * 2007-09-12 2017-05-16 Dr Reddy's Laboratories Inc bortezomib e processo para a produção do mesmo
US7838673B2 (en) 2007-10-16 2010-11-23 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
EA201500431A1 (ru) * 2008-06-17 2015-11-30 Милленниум Фармасьютикалз, Инк. Соединения боронатного эфира и его фармацевтические составы
AU2013204896A1 (en) * 2008-09-29 2013-05-16 Millennium Pharmaceuticals, Inc. Derivatives of 1-amino-2-cyclobutylethylboronic acid
AR075090A1 (es) 2008-09-29 2011-03-09 Millennium Pharm Inc Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
CN101899062B (zh) * 2009-05-26 2015-04-15 上海威智医药科技有限公司 α-手性硼酸及硼酸酯的合成工艺
EP2270019A1 (en) 2009-06-19 2011-01-05 LEK Pharmaceuticals d.d. New synthetic route for the preparation of alpha-amino boronic esters
EP2280016A1 (en) 2009-07-27 2011-02-02 LEK Pharmaceuticals d.d. New synthetic route for the preparation of alpha-amino boronic esters via substituted alk-1-ynes
JP2012530115A (ja) 2009-06-19 2012-11-29 レツク・フアーマシユーテイカルズ・デー・デー 置換アルカ−１−インを経由するα−アミノボロン酸誘導体の調製のための新規な合成経路
CA2785300A1 (en) 2009-12-22 2011-07-21 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
WO2011090940A1 (en) 2010-01-19 2011-07-28 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutic delivery
EP2534159A1 (en) 2010-02-09 2012-12-19 Ranbaxy Laboratories Limited Process for the preparation of bortezomib
CN101781326B (zh) * 2010-02-11 2013-08-21 福建南方制药股份有限公司 一种制备手性氨基硼酸的中间体及其制备方法
WO2011107912A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Polymorphic forms of bortezomib
US8263578B2 (en) 2010-03-18 2012-09-11 Innopharma, Inc. Stable bortezomib formulations
RU2529800C2 (ru) * 2010-03-18 2014-09-27 ИННОФАРМА, Инк. Стабильные составы бортезомиба
RU2012146101A (ru) 2010-03-31 2014-05-10 Милленниум Фармасьютикалз, Инк. Производные 1-амино-2-циклопропилэтилбороновой кислоты
CN101812026B (zh) * 2010-04-12 2013-08-28 亚邦医药股份有限公司 一种硼替佐米的合成方法
EP3566719A1 (en) 2010-05-18 2019-11-13 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
EP2627636B1 (en) 2010-10-14 2015-09-02 Synthon BV Process for making bortezomib and the intermediates for the process
TW201309303A (zh) 2011-03-03 2013-03-01 Cephalon Inc 用於治療狼瘡的蛋白酶體抑制劑
CN102206188B (zh) * 2011-04-08 2013-02-27 苏州二叶制药有限公司 N-(吡嗪-2-基羰基)-l-苯丙氨酸的制备方法
US8497374B2 (en) 2011-05-12 2013-07-30 Scinopharm Taiwan, Ltd. Process for preparing and purifying bortezomib
CN102268029B (zh) * 2011-05-19 2013-10-09 苏州二叶制药有限公司 化合物（1s,2s,3r,5s）-蒎烷二醇-l-苯丙氨酸-l-亮氨酸硼酸酯的制备
JP5944986B2 (ja) 2011-06-22 2016-07-05 セファロン、インク． プロテアソーム阻害剤、ならびにそれらの調製、精製、および使用のためのプロセス
CN102351890B (zh) * 2011-09-30 2014-07-02 重庆泰濠制药有限公司 一种硼替佐米的合成方法
CN102492021B (zh) * 2011-12-13 2013-10-23 重庆泰濠制药有限公司 硼替佐米的制备工艺
US9688702B2 (en) * 2011-12-22 2017-06-27 Ares Trading Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
CN103374026A (zh) * 2012-04-27 2013-10-30 重庆医药工业研究院有限责任公司 一种硼替佐米中间体的制备方法
CN103450331B (zh) * 2012-06-05 2016-05-25 山东新时代药业有限公司 一种硼替佐米的精制方法
BR112015005343A2 (pt) * 2012-09-11 2017-07-04 Cipla Ltd processo para a preparação de bortezomib, composto, bortezomib ou seu anidrido, e, processo para a preparação de um composto
WO2014072985A1 (en) 2012-11-06 2014-05-15 Natco Pharma Limited Novel boronic acid derivatives as anti cancer agents
JP2015536342A (ja) 2012-11-16 2015-12-21 シルパ・メディケア・リミテッドＳｈｉｌｐａ Ｍｅｄｉｃａｒｅ Ｌｉｍｉｔｅｄ 結晶ボルテゾミブの方法
RU2654692C2 (ru) 2012-12-07 2018-05-22 Венаторкс Фармасьютикалс, Инк. Ингибиторы бета-лактамаз
CN103897027A (zh) * 2012-12-29 2014-07-02 曹亚英 关键中间体晶型，制备方法及其在硼替佐米合成中的运用
CN103897026A (zh) * 2012-12-29 2014-07-02 朱继东 硼替佐米关键中间体的晶型，制备方法及其运用
EP2943204B1 (en) 2013-01-10 2019-03-13 Venatorx Pharmaceuticals Inc Beta-lactamase inhibitors
WO2014170628A1 (en) 2013-04-16 2014-10-23 Cipla Limited Process for the preparation of bortezomib mannitol ester
CN104211758B (zh) * 2013-05-29 2020-06-12 深圳翰宇药业股份有限公司 一种硼替佐米的制备方法
CN103497233B (zh) * 2013-09-30 2015-04-08 哈药集团技术中心 一种硼替佐米的制备方法
CN103554219A (zh) * 2013-10-01 2014-02-05 昆明贵研药业有限公司 一种制备硼替佐米的方法
KR101691353B1 (ko) * 2013-12-09 2016-12-30 주식회사 경보제약 보르테조밉의 제조방법 및 그의 신규 중간체
US10167311B2 (en) 2014-02-03 2019-01-01 Ohio State Innovation Foundation Boronic acid esters and pharmaceutical formulations thereof
AU2015264272A1 (en) 2014-05-20 2016-11-24 Millennium Pharmaceuticals, Inc. Boron-containing proteasome inhibitors for use after primary cancer therapy
CN109988186A (zh) 2014-06-11 2019-07-09 维纳拓尔斯制药公司 β-内酰胺酶抑制剂
JP6420629B2 (ja) * 2014-10-30 2018-11-07 ボーグワーナー インコーポレーテッド チェーンガイドおよびチェーンテンショナアーム
DE102015204151A1 (de) * 2015-03-09 2016-09-15 Adidas Ag Ball, insbesondere Fußball, und Verfahren zur Herstellung eines Balls
JP6223508B2 (ja) * 2016-06-27 2017-11-01 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． プロテアソーム阻害剤
WO2018027062A1 (en) 2016-08-04 2018-02-08 VenatoRx Pharmaceuticals, Inc. Boron-containing compounds
WO2018150386A1 (en) 2017-02-17 2018-08-23 Fresenius Kabi Oncology Ltd. An improved process for the preparation of boronic acid esters
JP2020510661A (ja) 2017-03-06 2020-04-09 ベナトルクス ファーマシューティカルズ，インク． β−ラクタマーゼ阻害剤を含む固体形態及び組み合わせ組成物並びにその使用
US11332485B2 (en) 2017-05-26 2022-05-17 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
EP3630783A4 (en) 2017-05-26 2021-03-03 Venatorx Pharmaceuticals, Inc. PENICILLIN BINDING PROTEIN INHIBITORS
WO2019020099A1 (zh) 2017-07-28 2019-01-31 成都地奥九泓制药厂 一种硼酸酯化合物、其合成方法及其用途
CN111065641A (zh) 2017-09-02 2020-04-24 太阳制药工业有限公司 柠檬酸伊沙佐米的制备方法
CN111187336B (zh) * 2018-11-14 2022-05-20 正大天晴药业集团股份有限公司 硼替佐米的精制方法
US11964993B2 (en) 2021-07-03 2024-04-23 Shilpa Pharma Lifesciences Limited Crystalline bortezomib process

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525309A (en) * 1983-03-15 1985-06-25 Washington State University Research Foundation, Inc. Lewis acid catalysis of the homologation of boronic esters with haloalkylmetal reagents
US4537773A (en) 1983-12-05 1985-08-27 E. I. Du Pont De Nemours And Company α-Aminoboronic acid derivatives
US4499082A (en) 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
US4701545A (en) 1986-02-12 1987-10-20 Washington State University Research Foundation, Inc. Preparation of α,α-dihaloalkyl boronic esters
US5250720A (en) 1987-06-05 1993-10-05 The Dupont Merck Pharmaceutical Company Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
US5242904A (en) 1987-06-05 1993-09-07 The Dupont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (de) 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Renin-Inhibitoren
US5106948A (en) 1988-05-27 1992-04-21 Mao Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
ES2571219T3 (es) * 2001-01-25 2016-05-24 The United States Of America Represented By The Secretary Dept Of Health And Human Services Formulación de compuestos de ácido borónico
WO2003033507A1 (fr) * 2001-10-12 2003-04-24 Kyorin Pharmaceutical Co., Ltd. Derives d'acide benzylmalonique et inhibiteurs de proteasomes les contenant
WO2003033506A1 (fr) * 2001-10-12 2003-04-24 Kyorin Pharmaceutical Co., Ltd. Derive d'acide d'aminoborane et medicament inhibiteur de proteasomes le contenant
ME01975B (me) 2004-03-30 2015-05-20 Millennium Pharm Inc Sinteza jedinjenja estra organoborne kiseline i organoborne kiseline
WO2009004350A1 (en) * 2007-07-03 2009-01-08 Pliva Hrvatska D.O.O. Methods for preparing bortezomib and intermediates used in its manufacture
US7838673B2 (en) * 2007-10-16 2010-11-23 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
JP2012530115A (ja) * 2009-06-19 2012-11-29 レツク・フアーマシユーテイカルズ・デー・デー 置換アルカ−１−インを経由するα−アミノボロン酸誘導体の調製のための新規な合成経路

Also Published As

Publication number Publication date
UY34969A (es) 2015-02-27
HK1164320A1 (en) 2012-10-19
SI3385267T1 (sl) 2022-04-29
SG151322A1 (en) 2009-04-30
SI2377869T1 (sl) 2014-05-30
JP5894952B2 (ja) 2016-03-30
DK1756121T3 (da) 2012-01-09
CN1960996B (zh) 2016-04-20
EP2377869B1 (en) 2014-01-29
AU2005230930A1 (en) 2005-10-20
US20190112334A1 (en) 2019-04-18
SG182998A1 (en) 2012-08-30
SG10201600029PA (en) 2016-02-26
CA2853272A1 (en) 2005-10-20
CN103396427A (zh) 2013-11-20
EP3385267B1 (en) 2021-09-29
NO338905B1 (no) 2016-10-31
PT2377869E (pt) 2014-04-15
CA2560886A1 (en) 2005-10-20
US8283467B2 (en) 2012-10-09
CN108329337B (zh) 2021-06-25
AR049374A1 (es) 2006-07-26
AU2005230930B2 (en) 2011-09-29
CN107474062A (zh) 2017-12-15
PE20060162A1 (es) 2006-04-07
US20050240047A1 (en) 2005-10-27
PE20142402A1 (es) 2015-02-04
JP2007530687A (ja) 2007-11-01
KR100939598B1 (ko) 2010-02-01
US20190330270A1 (en) 2019-10-31
NO20191065A1 (no) 2006-12-22
NZ586824A (en) 2012-03-30
HK1246300A1 (zh) 2018-09-07
NL1028639A1 (nl) 2005-10-20
SG10201800972PA (en) 2018-03-28
WO2005097809A3 (en) 2006-02-16
CA2738706C (en) 2014-10-14
TW200616646A (en) 2006-06-01
PL2377869T3 (pl) 2014-07-31
AR097310A2 (es) 2016-03-02
US20100174072A1 (en) 2010-07-08
AR097309A2 (es) 2016-03-02
HK1100004A1 (en) 2007-08-31
US7714159B2 (en) 2010-05-11
ME01975B (me) 2015-05-20
SI1756121T1 (sl) 2012-03-30
US20210171574A1 (en) 2021-06-10
IL219853A (en) 2015-05-31
FI4008721T3 (fi) 2024-03-19
US20220204558A1 (en) 2022-06-30
HRP20212002T1 (hr) 2022-04-01
PT4008721T (pt) 2024-03-21
EP1756121B1 (en) 2011-08-24
ZA200608689B (en) 2007-09-26
EA012927B1 (ru) 2010-02-26
SG182999A1 (en) 2012-08-30
ES2899606T3 (es) 2022-03-14
US20200369722A1 (en) 2020-11-26
US20180265546A1 (en) 2018-09-20
US20150038706A1 (en) 2015-02-05
ECSP066960A (es) 2006-12-20
EP3385267A1 (en) 2018-10-10
WO2005097809A2 (en) 2005-10-20
CY1115336T1 (el) 2017-01-04
BRPI0509587A (pt) 2007-09-25
MX367324B (es) 2019-08-15
NO343966B1 (no) 2019-07-29
US20210395301A1 (en) 2021-12-23
PT3385267T (pt) 2021-11-23
NO20064893L (no) 2006-12-22
DOP2011000293A (es) 2011-12-15
CN111925385B (zh) 2023-11-21
JP2013100378A (ja) 2013-05-23
CN111925385A (zh) 2020-11-13
US20200157143A1 (en) 2020-05-21
CL2014002252A1 (es) 2014-12-05
JP2010241816A (ja) 2010-10-28
JP4558039B2 (ja) 2010-10-06
RS62738B1 (sr) 2022-01-31
CN103396427B (zh) 2018-04-13
IL219856A0 (en) 2012-06-28
PL3385267T3 (pl) 2022-02-14
CY1112053T1 (el) 2015-11-04
HRP20110846T1 (hr) 2011-12-31
JP5414625B2 (ja) 2014-02-12
UY28830A1 (es) 2005-09-30
US10000529B2 (en) 2018-06-19
DK3385267T3 (da) 2021-11-01
EA200601795A1 (ru) 2007-04-27
UA90108C2 (uk) 2010-04-12
JP2016056180A (ja) 2016-04-21
CN1960996A (zh) 2007-05-09
DK2377869T3 (da) 2014-04-14
CN108329337A (zh) 2018-07-27
RS53259B (sr) 2014-08-29
KR20070007873A (ko) 2007-01-16
TWI386212B (zh) 2013-02-21
US20160362449A1 (en) 2016-12-15
PE20110075A1 (es) 2011-02-17
IL219856A (en) 2015-05-31
US9862745B2 (en) 2018-01-09
EP1756121A2 (en) 2007-02-28
CR8653A (es) 2007-10-23
IL178250A (en) 2012-06-28
NL1033189C2 (nl) 2008-08-14
PT1756121E (pt) 2011-11-30
IL219853A0 (en) 2012-06-28
CA2560886C (en) 2014-08-12
NZ550522A (en) 2010-08-27
CA2738706A1 (en) 2005-10-20
HUE056859T2 (hu) 2022-03-28
NZ598172A (en) 2013-08-30
LT3385267T (lt) 2021-11-10
JP6193960B2 (ja) 2017-09-06
ES2371652T3 (es) 2012-01-05
DK4008721T3 (da) 2024-03-25
EP2377869A1 (en) 2011-10-19
NL1033189A1 (nl) 2007-10-22
EP4008721A1 (en) 2022-06-08
ATE521612T1 (de) 2011-09-15
EP4008721B1 (en) 2024-01-03
NO344610B1 (no) 2020-02-10
PL1756121T3 (pl) 2012-02-29
HK1257298A1 (zh) 2019-10-18
NL1033190A1 (nl) 2007-04-23
IL178250A0 (en) 2006-12-31
LT4008721T (lt) 2024-03-25
UY35578A (es) 2016-01-08
CY1124753T1 (el) 2022-07-22
CA2859119A1 (en) 2005-10-20
NO20161350A1 (no) 2006-12-22
NO20171939A1 (no) 2006-12-22
EP2377868A1 (en) 2011-10-19
US20180044377A1 (en) 2018-02-15
HRP20140339T1 (hr) 2014-05-09
ES2457593T3 (es) 2014-04-28
NL1033190C2 (nl) 2007-11-27
MY145427A (en) 2012-02-15
CL2010000350A1 (es) 2011-01-28
NL1028639C2 (nl) 2007-01-17
RS51983B (sr) 2012-02-29
US20130005968A1 (en) 2013-01-03

Similar Documents

Publication Publication Date Title
HK1257298A1 (zh) 硼的酯和酸化合物的合成
PT1778618E (pt) Síntese de trietilenotetraminas
IL186297A0 (en) N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
HK1157760A1 (en) Benzimidazol-carbonyl-pyridinyl-amino-propionic acid ethyl ester hemihydrate and use thereof
IL179538A0 (en) Synthesis of amino-alkoxy-heptanoic alkyl ester
EP1711484A4 (en) SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES
ZA200609727B (en) Carbonylation of ester
GB0410603D0 (en) Ester synthesis
ZA200900278B (en) Synthesis of 3-(5-nitrocyclohex-1-enyl)acrylic acid and esters thereof
HK1087098A1 (en) Synthesis of 2-chloromethyl-6-methylbenzoic acid esters
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles
PL381188A1 (pl) Biooczyszczanie kwaśnych odpadów
GB0421012D0 (en) Ester synthesis
SI1611083T1 (sl) Sinteza estrov 2-klorometil-6-metil-benzojske kisline
IL179151A0 (en) Synthesis of amino acid keto-epoxides
GB0428166D0 (en) Use of essentially fatty acid molecules
DOP2005000058A (es) Sintesis de compuestos de ester y acido borico
GB0428060D0 (en) Ester synthesis
SI1709057T1 (sl) Sinteza spongozina